Capsaicin (Qutenza®) patch

OFFICE ADMINISTRATION

Indications for Prior Authorization:

  • For diagnosis of Post herpetic Neuralgia (PHN)

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Any other diagnosis not listed in the approved indications

All of the following must be met:

  • Inadequate response, intolerable side effect(s) or contra-indication to at least two oral drugs [e.g. tricyclic antidepressants, anticonvulsants, opioids] and a self-administered topical patch [e.g. lidocaine patch] used for PHN, OR
  • If pt is ≥ 65 yrs old, inadequate response, intolerable side effect(s) or contra-indication to an oral drug [e.g. anticonvulsants, opioids] and a self administered topical patch [e.g. lidocaine patch] used for PHN

Dosing:

  • Up to 4 patches per treatment session, and not more frequently than every three months
  • Administration of Qutenza®:
    • Only physicians or health care professionals under the close supervision of a physician are to administer Qutenza®
    • Use only nitrile (not latex) gloves when handling Qutenza® and when cleaning treatment areas
    • Burning and erythema reported in majority of patients treated with Qutenza®

Approval:

Initial coverage for 3 months

Reauthorize yearly based upon continued response to treatment


 

Last review date: December 2, 2013

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.